Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors.

Cancers (Basel) · 2022 · PMC9313286 · PMID 35884377

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In the present study, when the PRRT reduction rate was evaluated according to the primary organ, a favorable trend in pan NET was observed, while rectal NET was found to be a significantly poor factor.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.